title: Comment: Increased D3 binding-A substrate for levodopa-induced dyskinesias?
authors.affiliation: From the Pacific Parkinson's Research Centre & National Parkinson Foundation Centre of Excellence, Division of Neurology & Djavad Mowafaghian Centre for Brain Health, University of British Columbia & Vancouver Coastal Health, Canada.
authors.forename: A Jon
authors.initials: AJ
authors.lastname: Stoessl
mesh_terms: D015259:Dopamine Agents / Q000009:adverse effects*; D004409:Dyskinesia, Drug-Induced / Q000000981:diagnostic imaging*; D005260:Female; D005917:Globus Pallidus / Q000000981:diagnostic imaging*; D006801:Humans; D007980:Levodopa / Q000009:adverse effects*; D008297:Male; D010300:Parkinson Disease / Q000000981:diagnostic imaging*; D049268:Positron-Emission Tomography / Q000379:methods*; D050637:Receptors, Dopamine D3 / Q000378:metabolism*
chemical_list: D015259:Dopamine Agents; D050637:Receptors, Dopamine D3; D007980:Levodopa